Skip to content
10-Q

Quarterly Report

NIGHTSTAR THERAPEUTICS PLC

0001564590-19-018158

← back to feed
Filed
May 10, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2019 · Apr 24, 2019 33.54M sh
Capex Q1 2019 · Mar 31, 2019 $14K
Capex Q1 2019 · Mar 31, 2018 $43K
Operating Cash Flow Q1 2019 · Mar 31, 2019 −$11.36M
Operating Cash Flow Q1 2019 · Mar 31, 2018 −$8.92M
Cash And Equivalents Q1 2019 · Mar 31, 2019 $94.51M
Cash And Equivalents Q1 2019 · Dec 31, 2018 $27.78M
Stockholders Equity Q1 2019 · Mar 31, 2019 $149.72M
Stockholders Equity Q1 2019 · Dec 31, 2018 $165.64M
Stockholders Equity Q1 2019 · Mar 31, 2018 $118.64M
Stockholders Equity Q1 2019 · Dec 31, 2017 $125.81M
Current Liabilities Q1 2019 · Mar 31, 2019 $19.66M
Current Liabilities Q1 2019 · Dec 31, 2018 $14.38M
Total Liabilities Q1 2019 · Mar 31, 2019 $20.01M
Total Liabilities Q1 2019 · Dec 31, 2018 $14.38M
Current Assets Q1 2019 · Mar 31, 2019 $167.83M
Current Assets Q1 2019 · Dec 31, 2018 $179.04M
Total Assets Q1 2019 · Mar 31, 2019 $169.73M
Total Assets Q1 2019 · Dec 31, 2018 $180.01M
Sga Expense Q1 2019 · Mar 31, 2019 $9.66M
Sga Expense Q1 2019 · Mar 31, 2018 $2.78M
Rd Expense Q1 2019 · Mar 31, 2019 $8.9M
Rd Expense Q1 2019 · Mar 31, 2018 $6.06M
Net Income Q1 2019 · Mar 31, 2019 −$16.39M
Net Income Q1 2019 · Mar 31, 2018 −$14.36M